Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (ανοίγει νέο παράθυρο)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

Πηγή‎: Cancer 2013;119(21):3784-7.

Καταχώριση‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (ανοίγει νέο παράθυρο)

Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. (ανοίγει νέο παράθυρο)

Avvisati G, ten Cate JW, Büller HR, Mandelli F.

Πηγή‎: Lancet 1989;334(8655):122-4.

Καταχώριση‎: PubMed 2567893

https://www.ncbi.nlm.nih.gov/pubmed/2567893 (ανοίγει νέο παράθυρο)

Tranexamic acid therapy in acute myeloid leukemia: possible reduction of platelet transfusions. (ανοίγει νέο παράθυρο)

Ben-Bassat I, Douer D, Ramot B.

Πηγή‎: Eur J Haematol 1990;45(2):86-9.

Καταχώριση‎: PubMed 2209824

https://www.ncbi.nlm.nih.gov/pubmed/2209824 (ανοίγει νέο παράθυρο)

Fibrinolytic inhibitors for cancer-associated bleeding problems. (ανοίγει νέο παράθυρο)

Dean A, Tuffin P.

Πηγή‎: J Pain Symptom Manage 1997;13(1):20-4.

Καταχώριση‎: PubMed 9029858

https://www.ncbi.nlm.nih.gov/pubmed/9029858 (ανοίγει νέο παράθυρο)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (ανοίγει νέο παράθυρο)

Ford PA, Grant SJ, Mick R, Keck G.

Πηγή‎: J Clin Oncol 2015;33(15):1674-9.

Καταχώριση‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (ανοίγει νέο παράθυρο)

Anti-fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patients. (ανοίγει νέο παράθυρο)

Garewal HS, Durie BG.

Πηγή‎: Scand J Haematol 1985;35(5):497-500.

Καταχώριση‎: PubMed 4089529

https://www.ncbi.nlm.nih.gov/pubmed/4089529 (ανοίγει νέο παράθυρο)

Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage. (ανοίγει νέο παράθυρο)

Kalmadi S, Tiu R, Lowe C, Jin T, Kalaycio M.

Πηγή‎: Cancer 2006;107(1):136-40.

Καταχώριση‎: PubMed 16708357

DOI‎: 10.1002/cncr.21958

https://www.ncbi.nlm.nih.gov/pubmed/16708357 (ανοίγει νέο παράθυρο)

Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series. (ανοίγει νέο παράθυρο)

Marshall A, Li A, Drucker A, Dzik W.

Πηγή‎: Hematol Oncol 2016;34(3):147-53.

Καταχώριση‎: PubMed 25641349

DOI‎: 10.1002/hon.2189

https://www.ncbi.nlm.nih.gov/pubmed/25641349 (ανοίγει νέο παράθυρο)

Tranexamic acid to treat life-threatening hemorrhage in prostate cancer associated disseminated intravascular coagulation with excessive fibrinolysis. (ανοίγει νέο παράθυρο)

Prokopchuk-Gauk O, Brose K.

Πηγή‎: Cureus 2015;7(12):e428.

Καταχώριση‎: PubMed 26848417

DOI‎: 10.7759/cureus.428

https://www.ncbi.nlm.nih.gov/pubmed/26848417 (ανοίγει νέο παράθυρο)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (ανοίγει νέο παράθυρο)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

Πηγή‎: Leuk Lymphoma 1995;19(1-2):141-4.

Καταχώριση‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (ανοίγει νέο παράθυρο)

Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients. (ανοίγει νέο παράθυρο)

Wassenaar T, Black J, Kahl B, Schwartz B, Longo W, Mosher D, Williams E.

Πηγή‎: Hematol Oncol 2008;26(4):241-6.

Καταχώριση‎: PubMed 18613223

DOI‎: 10.1002/hon.867

https://www.ncbi.nlm.nih.gov/pubmed/18613223 (ανοίγει νέο παράθυρο)

Use of Novoseven for arsenic trioxide-induced bleeding in PML. (ανοίγει νέο παράθυρο)

Alimoghaddam K, Ghavamzadeh A, Jahani M.

Πηγή‎: Am J Hematol 2006;81(9):720.

Καταχώριση‎: PubMed 16804937

DOI‎: 10.1002/ajh.20713

https://www.ncbi.nlm.nih.gov/pubmed/16804937 (ανοίγει νέο παράθυρο)

Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. (ανοίγει νέο παράθυρο)

Brenner B, Hoffman R, Balashov D, Shutluko E, Čulić SD, Nizamoutdinova E.

Πηγή‎: Clin Appl Thromb Hemost 2005;11(4):401-10.

Καταχώριση‎: PubMed 16244765

https://www.ncbi.nlm.nih.gov/pubmed/16244765 (ανοίγει νέο παράθυρο)

The off-label use of recombinant FVIIa in the treatment of a patient with T-cell non-Hodgkin lymphoma who developed intra-abdominal and intra-pleural hemorrhages followed by high-dose methotreaxate therapy. (ανοίγει νέο παράθυρο)

Erduran E, Bahadir A, Mutlu M.

Πηγή‎: Eur J Clin Med Oncol 2011;3(5):1-4.

Καταχώριση‎: EMBASE 2012295551

https://www.worldcat.org/title/european-journal-of-clinical-medical-oncology/oclc/645421559&referer=brief_results (ανοίγει νέο παράθυρο)

The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review. (ανοίγει νέο παράθυρο)

Franchini M, Veneri D, Lippi G.

Πηγή‎: Bone Marrow Transplant 2007;39(12):729-35.

Καταχώριση‎: PubMed 17417659

DOI‎: 10.1038/sj.bmt.1705670

https://www.ncbi.nlm.nih.gov/pubmed/17417659 (ανοίγει νέο παράθυρο)

Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. (ανοίγει νέο παράθυρο)

Gerotziafas GT, Zervas C, Gavrielidis G, Tokmaktsis A, Hatjiharissi E, Papaioannou M, Lazaridou A, Constantinou N, Samama MM, Christakis J.

Πηγή‎: Am J Hematol 2002;69(3):219-22.

Καταχώριση‎: PubMed 11891811

https://www.ncbi.nlm.nih.gov/pubmed/11891811 (ανοίγει νέο παράθυρο)

Use of recombinant activated factor VII in a Jehovah's Witness patient. (ανοίγει νέο παράθυρο)

Hsieh A, Cheong I.

Πηγή‎: Am J Emerg Med 2007;25(9):1085.e1-2.

Καταχώριση‎: PubMed 18022514

DOI‎: 10.1016/j.ajem.2007.03.007

https://www.ncbi.nlm.nih.gov/pubmed/18022514 (ανοίγει νέο παράθυρο)

Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. (ανοίγει νέο παράθυρο)

Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellqvist UH, Johansson JE, Glazer S, Hedner U.

Πηγή‎: Haemostasis 1996;26 Suppl 1:159-64.

Καταχώριση‎: PubMed 8904193

https://www.ncbi.nlm.nih.gov/pubmed/8904193 (ανοίγει νέο παράθυρο)

Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. (ανοίγει νέο παράθυρο)

Pamuk GE, Taşçi M, Oztürk E, Demir M.

Πηγή‎: Med Oncol 2010;27(1):16-9.

Καταχώριση‎: PubMed 19137431

DOI‎: 10.1007/s12032-008-9163-y

https://www.ncbi.nlm.nih.gov/pubmed/19137431 (ανοίγει νέο παράθυρο)

Recombinant factor VIIa for bleeding in refractory thrombocytopenia. (ανοίγει νέο παράθυρο)

Vidarsson B, Önundarson PT.

Πηγή‎: Thromb Haemost 2000;83(4):634-5.

Καταχώριση‎: PubMed 10780334

https://www.ncbi.nlm.nih.gov/pubmed/10780334 (ανοίγει νέο παράθυρο)

Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia. (ανοίγει νέο παράθυρο)

Zver S, Andoljšek D, Černelč P.

Πηγή‎: Eur J Haematol 2004;72(6):455-6.

Καταχώριση‎: PubMed 15128428

DOI‎: 10.1111/j.1600-0609.2004.00237.x

https://www.ncbi.nlm.nih.gov/pubmed/15128428 (ανοίγει νέο παράθυρο)

Management of bleeding complications of hematologic malignancies. (ανοίγει νέο παράθυρο)

Green D.

Πηγή‎: Semin Thromb Hemost 2007;33(4):427-34.

Καταχώριση‎: PubMed 17525900

DOI‎: 10.1055/s-2007-976178

https://www.ncbi.nlm.nih.gov/pubmed/17525900 (ανοίγει νέο παράθυρο)

Vitamin K deficiency in cancer patients referred to a hospital palliative care team with bleeding and the impact of vitamin K replacement on laboratory indicators of vitamin K status. (ανοίγει νέο παράθυρο)

Harrington DJ, Booth L, Dando N, Cottingham L, Beynon T.

Πηγή‎: Int J Lab Hematol 2013;35(4):457-9.

Καταχώριση‎: PubMed 23216984

DOI‎: 10.1111/ijlh.12035

https://www.ncbi.nlm.nih.gov/pubmed/23216984 (ανοίγει νέο παράθυρο)

Management of bleeding in patients with advanced cancer. (ανοίγει νέο παράθυρο)

Pereira J, Phan T.

Πηγή‎: Oncologist 2004;9(5):561-70.

Καταχώριση‎: PubMed 15477642

DOI‎: 10.1634/theoncologist.9-5-561

https://www.ncbi.nlm.nih.gov/pubmed/15477642 (ανοίγει νέο παράθυρο)

Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies. (ανοίγει νέο παράθυρο)

Castaman G, Bona ED, Schiavotto C, Trentin L, D'Emilio A, Rodeghiero F.

Πηγή‎: Haematologica 1997;82(5):584-7.

Καταχώριση‎: PubMed 9407726

https://www.ncbi.nlm.nih.gov/pubmed/9407726 (ανοίγει νέο παράθυρο)

Desmopressin and other synthetic vasopressin analogues in cancer treatment. (ανοίγει νέο παράθυρο)

Gomez DE, Ripoll GV, Girón S, Alonso DF.

Πηγή‎: Bull Cancer 2006;93(2):E7-12.

Καταχώριση‎: PubMed 16517412

https://www.ncbi.nlm.nih.gov/pubmed/16517412 (ανοίγει νέο παράθυρο)